Corpus ID: 27777848

The relation between parameters from homeostasis model assessment and glycemic control in type 2 diabetes.

@article{Dansuntornwong2007TheRB,
  title={The relation between parameters from homeostasis model assessment and glycemic control in type 2 diabetes.},
  author={Bantita Dansuntornwong and Suwannee Chanprasertyothin and Wallaya Jongjaroenprasert and Chardpraon Ngarmukos and Pongamorn Bunnag and Gobchai Puavilai and Boonsong Ongphiphadhanakul},
  journal={Journal of the Medical Association of Thailand = Chotmaihet thangphaet},
  year={2007},
  volume={90 11},
  pages={
          2284-90
        }
}
OBJECTIVE To determine the association of insulin sensitivity and pancreatic beta-cell function parameters assessed by the homeostasis model assessment (HOMA) and glycemic control, and their potential utilization in the clinical care of patients with type 2 diabetes mellitus. MATERIAL AND METHOD The HOMA indices were assessed in 204 (62 males, 142 females) type 2 diabetic outpatients aged 60.7 +/- 10.9 years. All patients were non-insulin treated for their diabetes. The correlation between… Expand
Post-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarbose
TLDR
In patients with T2DM inadequately controlled with metformin, add-on oral anti-diabetic agent with glibenclamide or acarbose resulted in the significant HbA1c reduction and improvement of β-cell function. Expand
Impact of plasmatic lipids in glycemic control and its influence in the cardiometabolic risk in morbidly obese subjects.
TLDR
The use of TG levels offers a reasonable degree of clinical utility and in morbidly obese subjects insulin resistance is associated with individual cardiometabolic factors. Expand
Function of ß-cells and insulin resistance in long-standing type 2 diabetes mellitus
TLDR
The highly reduced -cells function and the consequent insulin defi ciency, usually combined with the moderate insulin resistance was determined in the patients with a long-standing type 2 diabetes mellitus. Expand
COMPARISON OF DIFFERENT ASSESSMENT MODELS OF INSULIN RESISTANCE IN ROMANIAN OBESE PATIENTS
TLDR
The results show that the homeostasis model assessment parameters (HOMA) and the Quicki test (Quantitative insulin sensitivity check index) vary significantly in correlation with both weight and glucose level in a group of Romanian subjects. Expand
Glycaemic control in type 2 diabetes patients and its predictors: a retrospective database study at a tertiary care diabetes centre in Ningbo, China
TLDR
More than half of patients with T2DM at the diabetes centre in Ningbo, China have poor glycaemic control, and the predictors of glycaeme control were identified, which could be taken into consideration in future interventional studies aimed at improving glycaemia control. Expand
Effect of camel milk on glucose metabolism in adults with normal glucose tolerance and type 2 diabetes in Raica community: a crossover study.
TLDR
In type-2 diabetics camel milk reduces FBS, post-prandial glucose and HbA1c and aUC-insulin and AUC-glucose also decreased significantly along with HOMA-IR, showing hypoglycemic effect of camel milk reducing insulin resistance. Expand
Inflammatory Markers Associated with Chronic Hyperglycemia and Insulin Resistance
TLDR
It is clear that inflammation is a contributing factor in the pathogenesis of type 2 diabetes, and the precise molecular mechanism(s) linking insulin resistance to the development and/or progression of atherosclerosis remains under debate. Expand
5 Inflammatory Markers Associated with Chronic Hyperglycemia and Insulin Resistance
Chronic hyperglycemia associated with type 2 diabetes mellitus (T2D) is a result of deficient insulin secretion and/or resistance of target tissues to insulin’s action. Chronic hyperglycemia is aExpand
Additional dexamethasone in chemotherapies with carboplatin and paclitaxel could reduce the impaired glycometabolism in rat models
TLDR
Carboplatin and paclitaxel administration could cause a transient hyperglycemia in rats, which might occur by the combination of glucagon accumulation due to the decrease in islet cell secretion and the additional dexamethasone in the combination protocol seemed to reduce the impaired blood glucose metabolism. Expand

References

SHOWING 1-10 OF 40 REFERENCES
Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes.
TLDR
HOMA-IR may constitute a useful method not only for diagnosing insulin resistance, but also for follow-up during the treatment of patients with type 2 diabetes. Expand
Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.
TLDR
The HOMA IR strongly correlated with the clamp IR in type 2 diabetic patients treated with SUs as well as in those treated with diet alone. Expand
The Homeostasis Model in the San Antonio Heart Study
TLDR
HOMA provides a useful model to assess insulin resistance and β-cell function in epidemiological studies in which only fasting samples are available and that, further, it is critical to take into account the degree of insulin resistance in assessing insulin secretion by the HOMA model. Expand
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.
TLDR
The HOMA can be reliably used in large-scale or epidemiological studies in which only a fasting blood sample is available to assess insulin sensitivity and there is good agreement between the two methods in the categorization of subjects according to insulin sensitivity. Expand
A Prospective Analysis of the HOMA Model: The Mexico City Diabetes Study
TLDR
It is concluded that the HOMA provides a useful model to assess ²-cell function in epidemiological studies and that it is important to take into account the degree of IR in assessing insulin secretion. Expand
The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus
TLDR
improved insulin resistance and glycemic control, as well as Tg and HDL‐C–which suggests that pioglitazone may reduce cardiovascular risk for patients with type 2 diabetes. Expand
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
TLDR
Since intensive glucose control with metformin appears to decrease the risk of diabetes-related endpoints in overweight diabetic patients, and is associated with less weight gain and fewer hypoglycaemic attacks than are insulin and sulphonylureas, it may be the first-line pharmacological therapy of choice in these patients. Expand
Body mass index and waist circumference correlate to the same degree with insulin-mediated glucose uptake.
TLDR
BMI and WC correlate closely within an individual and equally well with IMGU, and BMI is as effective as WC in identifying insulin-resistant individuals. Expand
Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
TLDR
The correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop. Expand
Continuous infusion of glucose with model assessment: measurement of insulin resistance and β-cell function in man
TLDR
Continuous infusion of glucose with model assessment (CIGMA) is a new method of assessing glucose tolerance, insulin resistance and β-cell function in normal and Type 2 diabetic subjects who do not have glycosuria during the test. Expand
...
1
2
3
4
...